Insmed Incorporated

LSE:0JAV Stock Report

Market Cap: US$14.5b

Insmed Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0JAV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Feb 25SellUS$3,697,402Roger AdsettIndividual45,705US$80.90
07 Feb 25SellUS$2,678,925Martina FlammerIndividual33,115US$80.90
07 Feb 25SellUS$789John WiseIndividual10US$78.91
06 Feb 25SellUS$1,670,585Michael SmithIndividual20,650US$80.90
06 Feb 25SellUS$639,919John WiseIndividual7,910US$80.90
06 Feb 25SellUS$6,419,415William LewisIndividual79,350US$80.90
06 Feb 25SellUS$1,901,150S. SchaefferIndividual23,500US$80.90
06 Feb 25SellUS$2,296,751Sara BonsteinIndividual28,390US$80.90
10 Jan 25SellUS$242,816Michael SmithIndividual3,689US$66.21
10 Jan 25SellUS$995,012William LewisIndividual15,195US$66.02
10 Jan 25SellUS$236,274John WiseIndividual3,587US$66.21
10 Jan 25SellUS$312,260S. SchaefferIndividual4,770US$65.88
10 Jan 25SellUS$392,602Sara BonsteinIndividual6,000US$66.05
10 Jan 25SellUS$420,381Martina FlammerIndividual6,417US$66.16
10 Jan 25SellUS$368,472Roger AdsettIndividual5,624US$66.10
12 Aug 24SellUS$686,408S. SchaefferIndividual9,469US$72.49
28 May 24SellUS$78,418John WiseIndividual1,602US$48.95
14 May 24SellUS$129,362Michael SmithIndividual5,093US$25.40
14 May 24SellUS$566,493William LewisIndividual22,198US$25.52
14 May 24SellUS$129,591John WiseIndividual5,088US$25.47
14 May 24SellUS$166,149S. SchaefferIndividual6,508US$25.53
14 May 24SellUS$200,354Roger AdsettIndividual7,857US$25.50
14 May 24SellUS$280,748Sara BonsteinIndividual11,088US$25.32
14 May 24SellUS$271,001Martina FlammerIndividual10,640US$25.47

Insider Trading Volume

Insider Buying: 0JAV insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0JAV?
Owner TypeNumber of SharesOwnership Percentage
State or Government41,7700.0212%
Individual Insiders1,702,3410.865%
Hedge Funds12,960,5386.58%
Institutions182,207,11792.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.8%.

Top Shareholders

Top 25 shareholders own 69.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.2%
The Vanguard Group, Inc.
18,218,973US$1.5b6.28%0.02%
8.96%
BlackRock, Inc.
16,032,944US$1.3b7.1%0.02%
8.21%
T. Rowe Price Group, Inc.
14,687,117US$1.2b-1.15%0.1%
7.24%
Darwin Global Management Limited
12,960,538US$1.1b23.5%86.58%
3.98%
Capital Research and Management Company
7,116,997US$578.5m9.09%0.03%
3.41%
State Street Global Advisors, Inc.
6,106,153US$496.3m-1.17%0.02%
2.8%
Baker Bros. Advisors LP
5,006,863US$406.9m13.4%3.75%
2.7%
FMR LLC
4,825,808US$392.2m-32.6%0.02%
2.28%
Geode Capital Management, LLC
4,087,143US$332.2m7.18%0.02%
1.75%
Artisan Partners Limited Partnership
3,126,339US$254.1m8.4%0.19%
1.69%
JP Morgan Asset Management
3,031,633US$246.4m3.48%0.03%
1.69%
RTW Investments, LP
3,014,558US$245.0m-7.87%3.42%
1.59%
Columbia Management Investment Advisers, LLC
2,850,097US$231.6m10.5%0.05%
1.47%
Fidelity International Ltd
2,638,160US$214.4m8.13%0.08%
1.36%
William Blair Investment Management, LLC
2,433,443US$197.8m0.14%0.23%
1.32%
AllianceBernstein L.P.
2,363,561US$192.1m-3.53%0.06%
1.29%
Macquarie Investment Management Business Trust
2,313,159US$188.0m1.19%0.22%
1.1%
Pictet Asset Management Limited
1,959,718US$159.3m5.17%0.11%
1.05%
ClearBridge Investments, LLC
1,878,450US$152.7m3.85%0.11%
1.03%
Norges Bank Investment Management
1,833,810US$149.0m4.35%0.01%
1.02%
Principal Global Investors, LLC
1,820,782US$148.0m-2.84%0.07%
0.98%
Northern Trust Global Investments
1,750,642US$142.3m19.9%0.02%
0.96%
Franklin Resources, Inc.
1,713,965US$139.3m-25.4%0.05%
0.92%
Adage Capital Management, L.P.
1,647,562US$133.9m59.6%0.22%
0.9%
Suvretta Capital Management, LLC
1,611,561US$131.0m-1.48%4.57%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 09:06
End of Day Share Price 2025/02/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Insmed Incorporated is covered by 31 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Neena Bitritto-GargBaird
Anita DushyanthBerenberg
Jason ZemanskyBofA Global Research